SS
GILD icon

SBI Securities’s Gilead Sciences GILD Stock Holding History

SBI Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
18,046
-446
-2% -$58.8K 0.05% 182
2026
Q1 		$2.58M Sell
18,492
-1,356
-7% -$190K 0.07% 149
2025
Q4 		$2.44M Sell
19,848
-291
-1% -$35.4K 0.06% 170
2025
Q3 		$2.24M Sell
20,139
-593
-3% -$67.4K 0.06% 181
2025
Q2 		$2.3M Sell
20,732
-477
-2% -$50.8K 0.07% 169
2025
Q1 		$2.38M Sell
21,209
-138
-0.6% -$14.2K 0.08% 142
2024
Q4 		$1.97M Buy
+21,347
New +$1.92M 0.06% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities's GILD Position: Q2 2026 in Review

SBI Securities reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $58.8K and leaving 18,046 shares worth $2.28M. The position accounts for 0.05% of the portfolio, ranked #182.

SBI Securities first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.58M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SBI Securities held 18,046 shares of Gilead Sciences worth $2.28M as of Q2 2026.
  • SBI Securities sold 446 Gilead Sciences shares in Q2 2026, an estimated $58.8K.
  • Gilead Sciences made up 0.05% of SBI Securities's portfolio in Q2 2026, its #182 holding.
  • SBI Securities first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Gilead Sciences position peaked at $2.58M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.